Bharat Biotech, Gavi and UNICEF have reached an agreement to reduce the price of a malaria vaccine to €5.50 per dose from 2027. The 40% price cut is expected to save around $50 million over three years and help protect an additional one million children, marking a significant step towards making malaria prevention more accessible.
